Synthesis of a novel class of cyclophosphamide bis-spiropiperazinium salts

Abstract

Abstract: Based on the principle of association, a novel class of cyclophosphamide bis-spiropiperazinium compounds was designed and synthesized. A new method of synthesis, separation and purification for this kind of compounds was also developed.

Key words: Cyclophosphamide bis-spiropiperazinium salt, Cyclophosphamide bis-spiropiperazinium salt, Principle of association, Principle of association, Synthesis, Synthesis, Anti-cancer, Anti-cancer

CLC Number:

R916.41

Supporting:

Mo Liu, Ze-Mei Ge^*, Tie-Ming Cheng, Run-Tao Li^* . Synthesis of a novel class of cyclophosphamide bis-spiropiperazinium salts [J]. .

References

[1] (a) Sladek, N.E. Cancer Res. 1972, 32, 1848-1854; (b) Connors, T.A.; Cox, P.J.; Farmer, P.B.; Foster, A.B.; Jarman, M. Biochem. Pharmacol. 1974, 23, 115-129; (c) Friedman, O.M.; Myles, A.; Colvin, M. Adv. Cancer Chemother. 1979, 1, 143-204; (d) Sladek, N.E. Pharmacol. Ther. 1998, 37, 301-355.
[2] Brock, N.; Stekar, J.; Pohl, J.; Niemeyer, U.; Scheffler, G. Arzneim-Forsch. Drug Res. 1979, 29, 659-661.
[3] Eibl, H.; Kolar, C.; Seiler, F.R. EP 72531, 1982.
[4] Moon, K.Y.; Shirota, F.N.; Baturay, N.; Kwon, Ch.H. J. Med. Chem. 1995, 38, 848-851.
[5] (a) Engel, J.; Kleemann, A.; Niemeyer, U. Ger. Offen. DE 3505482, 1985; (b) Scheffler, G.; Niemeyer, U.; Brock, N. US 4618692, 1986.
[6] Boyd, V.L.; Zon, G.; Himes, V.L.; Stalick, J.K.; Mighell, A.D.; Secor, H.V. J. Med. Chem. 1980, 23, 372-375.
[7] Brandt, J.A.; Ludeman, S.M.; Zon, G.; Egan, W.; Todhunter, J.A.; Dickerson, R. J. Med. Chem. 1981, 24, 1404-1408.
[8] Borch, R.F.; Canute, G.W. J. Med. Chem. 1991, 34, 3044-3052.
[9] Ludeman, S.M.; Zon, G. J. Med. Chem. 1975, 18, 1251-1253.
[10] Li, Z.; Han, J.; Jiang, Y.; Browne, P.; Knox, R.J.; Hu, L. Bioorg. Med. Chem. 2003, 11, 4171-4178.
[11] Borch, R.F.; Valente, R.R. J. Med. Chem. 1991, 34, 3052-3058.
[12] Tietze, L.F.; Neumann, M.; Fischer, R. Ger. Offen., DE 3819634, 1989.
[13] Firestone, A.; Mulcahy, R.T.; Borch, R.F. J. Med. Chem. 1991, 34, 2933-2935.
[14] (a) Borch, R.F.; Liu, J.; Schmidt, J.P.; Marakovits, J.T.; Joswig, C. J. Med. Chem. 2000, 43, 2258-2265; (b) Borch, R.F.; Liu, J.; Joswig, C.; Baggs, R.B.; Dexter, D.L.; Mangold, G.L. J. Med. Chem. 2001, 44, 74-77.
[15] Steinberg, G.; Borch, R.F. J. Med. Chem. 2001, 44, 69-73.
[16] Flader, C.; Liu, J.; Borch, R.F. J. Med. Chem. 2000, 43, 3157-3167.
[17] Hernick, M.; Flader, C.; Borch, R.F. J. Med. Chem. 2002, 45, 3540-3548.
[18] Jain, M.; Fan, J.; Baturay, N.Z.; Kwon, C.H. J. Med. Chem. 2004, 47, 3843-3852.
[19] Jiang,Y.Y.; Hu, L.Q. J. Med. Chem. 2006, 49, 4333-4343.
[20] Jiang,Y.Y.; Hu, L.Q. Bioorg. Med. Chem. Lett. 2007, 17, 517-521.
[21] Jiang,Y.Y.; Hu, L.Q. Bioorg. Med. Chem. Lett. 2008, 18, 4059-4063.
[22] Safonova, T.S.; Chernov, V.A.; Minakova, S.M.; Dorokhova, M.I.; Levkovskaya, L.G.; Traven, N.I.; Andreyanova, T.A.; Serochkina, L.A.; Mamaeva, I.E. Khim. Farm. Zh. 1983, 17, 626-629.
[23] Safonova, T.S.; Minakova, S.M.; Chernov, V.A.; Andreyanova, T.A.; Deev, V.V. Khim. Farm. Zh. 1984, 18, 1437-1440.
[24] (a) Li, R.T.; Chen, H.C.; Yang, J.Z. Acta Pharm. Sin. 1995, 30, 63-69; (b) Li, R.T.; Chen, H.C.; Yang, J.Z. Acta Pharm. Sin. 1995, 30, 144-149.
[25] (a) Dong, J.C.; Wang, X.; Li, R.T.; Zhang, H.M.; Cheng, T.M.; Li, C.L. Bioorg. Med. Chem. Lett. 2003, 13, 4327-4329; (b) Liu, H.; Cheng, T.M.; Zhang, H. M.; Li, R.T. Arch. Pharm. Pharm. Med. Chem. 2003, 336, 510-513; (c) Wang, X.; Gao, F.L.; Piao, H.B.; Cheng, T.M.; Li, R.T. Bioorg. Med. Chem. Lett. 2003, 13, 1729-1732; (d) Gao, F.L.; Wang, X.; Zhang, H.M.; Cheng, T.M.; Li, R.T. Bioorg. Med. Chem. Lett. 2003, 13, 1535-1537.
[26] Li, R.T.; Sun, Q.; Ge, Z.M.; Cui, J.R.; Cheng, T.M. CN 1607204, 2005 [Chem. Abstr. 143, 460282].